UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug resistance and new therapies in colorectal cancer

World journal of gastroenterology : WJG, 2018-09, Vol.24 (34), p.3834-3848

2018

Volltextzugriff (PDF)

Direct-acting antivirals for chronic hepatitis C

Cochrane database of systematic reviews, 2017-06, Vol.6 (6), p.CD012143

2017

Volltextzugriff (PDF)

Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2

Viruses, 2021-06, Vol.13 (7), p.1228

2021

Volltextzugriff (PDF)

Angiogenesis Inhibitors: Current Strategies and Future Prospects

CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.222-243

2010

Volltextzugriff (PDF)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2

British journal of pharmacology, 2020-07, Vol.177 (14), p.3147-3161

2020

Volltextzugriff (PDF)

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy

British journal of haematology, 2013-06, Vol.161 (5), p.688-694

2013

Volltextzugriff (PDF)

Direct-acting antivirals for chronic hepatitis C

Cochrane database of systematic reviews, 2017-09, Vol.9 (9), p.CD012143

2017

Volltextzugriff (PDF)

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

Blood, 2013-03, Vol.121 (10), p.1720-1728

2013

Volltextzugriff (PDF)

C 60 fullerene against SARS-CoV-2 coronavirus: an in silico insight

Scientific reports, 2021-09, Vol.11 (1), p.17748

2021

Volltextzugriff (PDF)

Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?

PLoS genetics, 2017-08, Vol.13 (8), p.e1006842

2017

Volltextzugriff (PDF)

New approaches for treating staphylococcal biofilm infections

Annals of the New York Academy of Sciences, 2011-12, Vol.1241 (1), p.104-121

2011

Volltextzugriff (PDF)

Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy

Trends in cancer, 2021-02, Vol.7 (2), p.98-111

2021

Volltextzugriff (PDF)

Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus

The Journal of infectious diseases, 2018-03, Vol.217 (6), p.887-896

2018

Volltextzugriff (PDF)

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

British journal of haematology, 2016-03, Vol.172 (5), p.786-793

2016

Volltextzugriff (PDF)

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-03, Vol.13 (3), p.268-275

2014

Volltextzugriff (PDF)

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances

Cold Spring Harbor perspectives in medicine, 2021-04, Vol.11 (4), p.a038463

2021

Volltextzugriff (PDF)

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Blood, 2012-02, Vol.119 (6), p.1363-1369

2012

Volltextzugriff (PDF)

Efficacy of BCG vaccine and Mitomycin C for the treatment of ocular squamous cell carcinoma in bovines

Research in veterinary science, 2020-12, Vol.133, p.48-52

2020

Volltextzugriff (PDF)

Does bleb needling augmented by mitomycin C or 5‐fluorouracil share similar efficacy with no antimetabolites?

Acta ophthalmologica (Oxford, England), 2021-08, Vol.99 (5), p.e772-e772

2021

Volltextzugriff (PDF)

Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008

Antiviral research, 2018-06, Vol.154, p.104-109

2018

Volltextzugriff (PDF)

Translesion DNA Synthesis and Reinitiation of DNA Synthesis in Chemotherapy Resistance

Biochemistry (Moscow), 2020-08, Vol.85 (8), p.869-882

2020

Volltextzugriff (PDF)

Antiviral Resistance in Influenza Viruses — Implications for Management and Pandemic Response

The New England journal of medicine, 2006-02, Vol.354 (8), p.785-788

Hayden, Frederick G

2006

Volltextzugriff (PDF)

Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair

Genes, 2021-08, Vol.12 (9), p.1310

2021

Volltextzugriff (PDF)

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Journal of hepatology, 2014-11, Vol.61 (1), p.S98-S107

2014

Volltextzugriff (PDF)

Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C

Journal of hepatology, 2014-11, Vol.61 (1), p.S91-S97

2014

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Aktive Filter

KollektionBMJ

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)

Publikationsform

Artikel
(349)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(299)
Science & Technology
(299)
Life Sciences & Biomedicine
(297)
Nucleic Acid Synthesis Inhibitors - Therapeutic Use
(231)
Biological And Medical Sciences
(137)
Medical Sciences
(131)
Female
(127)
Male
(127)
Animals
(103)
Pharmacology. Drug Treatments
(85)
Adult
(83)
Nucleic Acid Synthesis Inhibitors
(80)
Middle Aged
(77)
Mitomycin - Therapeutic Use
(69)
Antiviral Agents - Therapeutic Use
(66)
Hydroxyurea - Therapeutic Use
(60)
Pharmacology & Pharmacy
(58)
Aged
(57)
Treatment Outcome
(55)
Nucleic Acid Synthesis Inhibitors - Pharmacology
(48)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug resistance and new therapies in colorectal cancer

Direct-acting antivirals for chronic hepatitis C

Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy

Direct-acting antivirals for chronic hepatitis C

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

C 60 fullerene against SARS-CoV-2 coronavirus: an in silico insight

Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?

New approaches for treating staphylococcal biofilm infections

Targeting the DNA Repair Enzyme Polymerase θ in Cancer Therapy

Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza Virus

Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial

Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Efficacy of BCG vaccine and Mitomycin C for the treatment of ocular squamous cell carcinoma in bovines

Does bleb needling augmented by mitomycin C or 5‐fluorouracil share similar efficacy with no antimetabolites?

Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008

Translesion DNA Synthesis and Reinitiation of DNA Synthesis in Chemotherapy Resistance

Antiviral Resistance in Influenza Viruses — Implications for Management and Pandemic Response

Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair

Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors

Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C

Aktive Filter

Suchergebnisse filtern